[KROS] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
06-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -48.79%
YoY- -33.58%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 20,000 0 100 0 0 2,500 2,500 298.48%
PBT -4,942 -20,335 -15,622 -15,835 -10,676 -12,036 -10,757 -40.37%
Tax 1,998 -38 -79 50 82 -156 1 15545.33%
NP -6,940 -20,297 -15,622 -15,885 -10,676 -12,036 -10,757 -25.27%
Tax Rate - - - - - - - -
Total Cost 26,940 20,297 15,722 15,885 10,676 14,536 13,257 60.22%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -34.70 0.00 -15,622.00 0.00 0.00 -481.44 -430.28 -81.24%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -0.30 -0.87 -0.67 -0.68 -0.49 -0.60 -0.61 -37.61%
EPS Diluted -0.30 -0.87 -0.67 -0.68 -0.49 -0.60 -0.61 -37.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.